435 related articles for article (PubMed ID: 30581068)
1. Interleukin-13: A promising therapeutic target for autoimmune disease.
Mao YM; Zhao CN; Leng J; Leng RX; Ye DQ; Zheng SG; Pan HF
Cytokine Growth Factor Rev; 2019 Feb; 45():9-23. PubMed ID: 30581068
[TBL] [Abstract][Full Text] [Related]
2. Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
Rafael-Vidal C; Pérez N; Altabás I; Garcia S; Pego-Reigosa JM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993066
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of interleukin-22 in autoimmune diseases.
Pan HF; Li XP; Zheng SG; Ye DQ
Cytokine Growth Factor Rev; 2013 Feb; 24(1):51-7. PubMed ID: 22906768
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D; DeClerck LS; Bridts CH; Stevens WJ
In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
[TBL] [Abstract][Full Text] [Related]
5. Cellular targeting in autoimmunity.
Rogers JL; Serafin DS; Timoshchenko RG; Tarrant TK
Curr Allergy Asthma Rep; 2012 Dec; 12(6):495-510. PubMed ID: 23054625
[TBL] [Abstract][Full Text] [Related]
6. [Regulatory T cells and systemic autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis, primary Sjögren's syndrome].
Bernard F; Romano A; Granel B
Rev Med Interne; 2010 Feb; 31(2):116-27. PubMed ID: 19962219
[TBL] [Abstract][Full Text] [Related]
7. [Prospects of the use of cyclosporin A in rheumatic diseases].
Nasonov EL; Shtutman VZ; Nasonova VA
Klin Med (Mosk); 1994; 72(5):12-9. PubMed ID: 7853807
[No Abstract] [Full Text] [Related]
8. Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile.
Spadaro A; Rinaldi T; Riccieri V; Taccari E; Valesini G
Clin Exp Rheumatol; 2002; 20(2):213-6. PubMed ID: 12051401
[TBL] [Abstract][Full Text] [Related]
9. B-cell depletion and repopulation in autoimmune diseases.
Pers JO; Daridon C; Bendaoud B; Devauchelle V; Berthou C; Saraux A; Youinou P
Clin Rev Allergy Immunol; 2008 Feb; 34(1):50-5. PubMed ID: 18270858
[TBL] [Abstract][Full Text] [Related]
10. [Biological therapy of arthritis and systemic autoimmune diseases].
Tamási L; Szekanecz Z
Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune connective tissue disease, chronic polyarthritides and B cell expansion: risks and perspectives with immunosuppressive drugs.
Ferraccioli GF; De Vita S; Casatta L; Damato R; Pegoraro I; Bartoli E
Clin Exp Rheumatol; 1996; 14 Suppl 14():S71-80. PubMed ID: 8722204
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.
Szabó K; Papp G; Szántó A; Tarr T; Zeher M
Clin Exp Immunol; 2016 Jan; 183(1):76-89. PubMed ID: 26358223
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune diseases in China.
Li R; Sun X; Liu X; Yang Y; Li Z
Adv Immunol; 2019; 144():173-216. PubMed ID: 31699217
[TBL] [Abstract][Full Text] [Related]
14. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity.
Llorente L; Richaud-Patin Y; Fior R; Alcocer-Varela J; Wijdenes J; Fourrier BM; Galanaud P; Emilie D
Arthritis Rheum; 1994 Nov; 37(11):1647-55. PubMed ID: 7980676
[TBL] [Abstract][Full Text] [Related]
15. Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases.
Pan HF; Leng RX; Li XP; Zheng SG; Ye DQ
Cytokine Growth Factor Rev; 2013 Dec; 24(6):515-22. PubMed ID: 25215394
[TBL] [Abstract][Full Text] [Related]
16. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-9 and T helper type 9 cells in rheumatic diseases.
Ciccia F; Guggino G; Ferrante A; Cipriani P; Giacomelli R; Triolo G
Clin Exp Immunol; 2016 Aug; 185(2):125-32. PubMed ID: 27159882
[TBL] [Abstract][Full Text] [Related]
18. A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases.
Simon Q; Grasseau A; Boudigou M; Le Pottier L; Bettachioli E; Cornec D; Rouvière B; Jamin C; Le Lann L; ; ; Borghi MO; Aguilar-Quesada R; Renaudineau Y; Alarcón-Riquelme ME; Pers JO; Hillion S
Arthritis Rheumatol; 2021 Aug; 73(8):1550-1561. PubMed ID: 33605069
[TBL] [Abstract][Full Text] [Related]
19. The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases.
Mirzaei R; Zamani F; Hajibaba M; Rasouli-Saravani A; Noroozbeygi M; Gorgani M; Hosseini-Fard SR; Jalalifar S; Ajdarkosh H; Abedi SH; Keyvani H; Karampoor S
J Neuroimmunol; 2021 Sep; 358():577640. PubMed ID: 34224949
[TBL] [Abstract][Full Text] [Related]
20. The autoimmunity-oral microbiome connection.
Nikitakis NG; Papaioannou W; Sakkas LI; Kousvelari E
Oral Dis; 2017 Oct; 23(7):828-839. PubMed ID: 27717092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
